000 03674nlm1a2200409 4500
001 657383
005 20231030041508.0
035 _a(RuTPU)RU\TPU\network\23885
090 _a657383
100 _a20180129a2017 k y0engy50 ba
101 0 _aeng
135 _adrcn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aRecent Advances of Individual BODIPY and BODIPY-Based Functional Materials in Medical Diagnostics and Treatment
_fYu. S. Marfin [et al.]
203 _aText
_celectronic
300 _aTitle screen
330 _aBackground: The group of fluorophores on boron dipyrrin platform (4,4- difluoro-4-bora3a,4a-diaza-s-indacene, also known as BODIPY) has attracted much attention in the field of molecular sensorics, including sensing of biomolecules and bioprocesses. Structural diversity of existing BODIPY with ample opportunities of directed modification of compounds makes this class of fluorophores attractive for medical and biological purposes. The recent progress in the design and functionalization of BODIPY allows using them for modification of drug micro- and nanocarriers in order to improve their therapeutic effect in cancer treatment. At the same time, integration of BODIPY into drug carriers provides the possibility of in vitro and in vivo real time imaging of used drug carriers. The high fluorescent intensity and low toxicity of BODIPY granted for conjugation with different biomolecules.Results: The present review focuses on the recent advances for application of individual BODIPY in medical diagnostics, antimicrobial activity, as well as establishing the role of BODIPY in labeling of biomolecules (e.g. proteins, hormones and DNA). Also the review highlights the potential of BODIPY in functionalization of drug micro- and nanocarriers in order to achieve better therapeutic efficiency compared with non-modified materials. The advantages derived from the use of BODIPY for preparation and modification of drug carriers are critically evaluated and potential for future challenges, especially concerning the design of innovative multi-functional BODIPY-based nanocarriers, is discussed in detail using representative examples from literature.Conclusion: Our objective was to show that BODIPY are powerful tools for bioimaging, labeling of biomolecules and construction of new multifunctional drug carriers.
333 _aРежим доступа: по договору с организацией-держателем ресурса
461 _tCurrent Medicinal Chemistry
463 _tVol. 24, iss. 25
_v[P. 2745-2772]
_d2017
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
610 1 _aздравоохранение
610 1 _aантимикробная активность
610 1 _aДНК
610 1 _aРНК
610 1 _aмедицинская диагностика
610 1 _aлекарственные препараты
701 1 _aMarfin
_bYu. S.
_gYuriy
701 1 _aSolomonov
_bA. V.
_gAlexey
701 1 _aTimin
_bA. S.
_cChemist
_cAssociate Scientist of Tomsk Polytechnic University
_f1989-
_gAleksandr Sergeevich
_2stltpush
_3(RuTPU)RU\TPU\pers\37036
701 1 _aRumyantsev
_bE. V.
_gEvgeniy
712 0 2 _aНациональный исследовательский Томский политехнический университет (ТПУ)
_bИсследовательская школа химических и биомедицинских технологий (ИШХБМТ)
_h8120
_2stltpush
_3(RuTPU)RU\TPU\col\23537
801 2 _aRU
_b63413507
_c20180220
_gRCR
856 4 _uhttps://doi.org/10.2174/0929867324666170601092327
942 _cCF